Yarrow Bioscience, Inc.
1 clinical trials · Sponsor
◉ Watch Yarrow Bioscience, Inc.
| Record | Firm | Date |
|---|---|---|
| Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease (NCT07682896) | Yarrow Bioscience, Inc. | 2026-06-10 |
Track Yarrow Bioscience, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.